Original Source(s)
Related Content
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
Guselkumab Shows Psoriasis Benefit in Darker Skin Tones
Randomized trial suggests sustained clearance across darker skin tones.
May 14, 2026
-
3 min
Low-Dose Oral Minoxidil Monitoring Questioned
A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.
May 14, 2026
-
6 min